Please login to the form below

Not currently logged in
Email:
Password:

Ebola

This page shows the latest Ebola news and features for those working in and with pharma, biotech and healthcare.

Janssen’s quest to prevent diseases taking hold

Janssen’s quest to prevent diseases taking hold

and respiratory tract that affects children and the elderly, and pathogens such as Ebola. ... Its continuing work on Ebola has seen laboratory results that suppress the virus over 18 months and increased promise of an effective vaccine.

Latest news

More from news
Approximately 21 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Amazing Africa Amazing Africa

    HIV/AIDS, malaria, famine, Ebola: there is a reason why the World Health Organization (WHO) considers it to be the region confronting the most dramatic public health crisis across the globe.

  • The world is our laboratory The world is our laboratory

    We are also dedicated to developing a vaccine for Ebola. We committed $200m to accelerate and significantly expand the production of our Ebola vaccine programme. ... test, manufacture and deploy the Ebola vaccine regimen.

  • Wearables: the tangible product of the patient revolution Wearables: the tangible product of the patient revolution

    The opportunity is massive - in the public health arena, there exists the possibility that outbreaks of diseases such as Ebola or influenza could be seen and stopped before they become critical.

  • Can patient-centricity work for pharma? Can patient-centricity work for pharma?

    More recently, firms such as GSK and Janssen have gained kudos by working with governments to create a new Ebola vaccine, even though the costs for this will likely not be

  • Communicating in a crisis Communicating in a crisis

    Timeline of Ebola outbreak in West Africa. December 2013. Two-year-old child contracts Ebola virus in Guinea. ... J&J announces it will fast-track vaccine research. October 2014. EMA offers orphan drug benefits to Ebola drugs.

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Cool heads in a crisis?

    First there was Ebola and now there is Zika; two official World Health Organization (WHO) Public Health Emergencies of International Concern (PHEIC) within as many years.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics